...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Transfer of ZEN from RBC DI to TFSA

Hi All

I just received a reply from Sarah that Zenith will post a new "Management Estimate of fair value of a common share" by the end of this week, reflecting Jan 31, 2019 financials.

GLTA DYODD

Share
New Message
Please login to post a reply